SYNACT.ST Intrinsic
Value
As of 2024-12-11, the Intrinsic Value of SynAct Pharma AB (SYNACT.ST) is
-18.71 SEK. This SYNACT.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 10.92 SEK, the upside of SynAct Pharma AB is
-271.38%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-18.71 SEK
Intrinsic Value
SYNACT.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-18.71 - -18.71 |
-18.71 |
-271.38% |
| P/E |
(91.92) - (109.82) |
(107.98) |
-1088.8% |
| DDM - Stable |
(60.72) - (8,283.72) |
(4,172.22) |
-38307.1% |
| DDM - Multi |
(23.40) - (2,472.63) |
(46.26) |
-523.7% |
SYNACT.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
450.96 |
| Beta |
1.07 |
| Outstanding shares (mil) |
41.30 |
| Enterprise Value (mil) |
413.90 |
| Market risk premium |
5.10% |
| Cost of Equity |
6.18% |
| Cost of Debt |
5.00% |
| WACC |
6.18% |